Table of Content


Introduction
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Overview
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Therapeutics Development
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Therapeutics Assessment
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Companies Involved in Therapeutics Development
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Drug Profiles
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Dormant Projects
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Discontinued Products
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Primary Biliary Cholangitis (Primary Biliary Cirrhosis), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Primary Biliary Cholangitis (Primary Biliary Cirrhosis), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Abcuro Inc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Alexion Pharmaceuticals Inc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Allergan Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Cadila Healthcare Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Calliditas Therapeutics AB, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Dr. Falk Pharma GmbH, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Eli Lilly and Co, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Genfit SA, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by GenKyoTex SA, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Gilead Sciences Inc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by GlaxoSmithKline Plc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Kowa Co Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by MYR GmbH, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by NGM Biopharmaceuticals Inc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Novartis AG, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by PRISM Pharma Co Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline by Virobay Inc, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Dormant Projects, H2 2020
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Discontinued Products, H2 2020